TAZOREX

This brand name is authorized in Cyprus, Hong Kong, Malta, Tunisia

Active ingredients

The drug TAZOREX contains a combination of these active pharmaceutical ingredients (APIs):

1 Piperacillin UNII M98T69Q7HP - PIPERACILLIN SODIUM

Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis. Read about Piperacillin

2 Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM

Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes. Read about Tazobactam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01CR05	Piperacillin and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 62632
Country: MT	Medicines Authority	Identifier(s): AA188/01902
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6855091H